FDA Extends Comment Period for Genome Editing in New Plant Varieties Used for Foods

Summary

The Food and Drug Administration is extending the comment period for a docket to receive information and comments on the use of genome editing techniques to produce new plant varieties used for human or animal food, following requests for an extension from interested persons.